TickerFactsScreenerDevelopers

Xenon Pharmaceuticals Inc. (XENE) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $13.93M2012: $60.16M2013: $37.95M2014: $72.03M2015: $58.65M2016: $17.09M2017: $20.49M2018: $67.75M2019: $24.75M2020: $45.01M2021: $175.69M2022: $57.24M2023: $148.64M2024: $142.71M2025: $199.16M$199.16M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$199.16M+39.6%
2024$142.71M-4.0%
2023$148.64M+159.7%
2022$57.24M-67.4%
2021$175.69M+290.3%
2020$45.01M+81.8%
2019$24.75M-63.5%
2018$67.75M+230.7%
2017$20.49M+19.8%
2016$17.09M-70.9%
2015$58.65M-18.6%
2014$72.03M+89.8%
2013$37.95M-36.9%
2012$60.16M+332.0%
2011$13.93M—